Connect with us

Cannabis News

Greenhouse growers & suppliers at IFPA 2025

Published

4 months ago

on

For many exhibitors, the IFPA Global Show requires months of preparation. From choosing the best booth location, coming up with an attractive layout, to launching new products and organizing parties. Needless to say, a lot of time and effort goes into this highly anticipated event that some call the Super Bowl of products. Last week, it was finally here. On October 17th and 18th, approximately 20,000 attendees from more than 50 countries around the world converged on Anaheim, California for an expo, educational sessions, camaraderie, and more.

Among them were the big players in North American greenhouses, and when they are somewhere, we all know the suppliers will follow, and so will we. So today we are sharing a photo report of greenhouse growers and horticulture suppliers.

Click here for the photo report.

Want more? Click here for the photo report fresh produce industryhas Fresh produce companies in Latin Americaor, if you prefer flowers, gardening companies.

What’s in fashion?
So what about the show. Many new products were introduced and many of them were variants of a category. Salad kits in different flavors, adding new colors to an existing tomato line and continued focus on better varieties in the berry segment. In the mushroom category, a new soup kit was introduced. This year’s highlights were the asparagus products and a cucumber picking kit, which includes not only cucumbers but also spices and garlic. Fermentation also seems to be picking up steam, as evidenced by kombucha drinks and kimchee. Will these products continue to be included in the category?

© Marieke Hemmes | MMJDaily.com

Click here for a photo report of the show.

the snack
It’s not new, but it’s definitely expanding the range of products in the snack segment. More tomatoes and cucumbers and new snacks were launched, but the show floor also saw celery sticks that go in kid’s lunch packs, carrots with dips, berries in small snack containers and nuts for dessert. Also, the availability of products in the nuts segment is expanding with dragon nuts and dried grapefruit strips. Packaging options for snacks also continue to expand.

The show’s attendees couldn’t complain when it came to snacking. Many companies were testing products with Dubai’s chocolate-dipped strawberries being very popular. The avocado toast bar was a busy place, with people lining up to sip the different fruit juices they were trying.

Extending the growing season
On the growing side, some US growers have cited a tough year to date as prices for some vegetable products have been low. While it wasn’t a perfect summer on the East Coast, most of the fresh produce escaped the extremes, which resulted in good yields. The crops in California did not have to endure intense heat, which also benefited the production volume. Exhibition breeders and growers are increasingly focusing on extending growing seasons. In addition to US and Canadian producers, IFPA has a strong representation of Mexican producers who market their products in the US.

Floor design
There has been a significant change in the floor plan this year, as the Flower section is cut into another building opposite the product display. The floral exhibition opened an hour earlier to give attendees more time to visit both exhibitions. The reason for creating a separate exhibition space for Floral was related to space, as the segment has seen a lot of growth in recent years. The Anaheim convention center can no longer accommodate both shows on one floor, but when the show returns to Orlando in 2026, the segments will likely be reunited.

Overall, exhibitors were happy with the floor plan design and turnout. The first day was definitely more crowded than the second day, but that is no longer surprising. However, some exhibitors mentioned that they missed the presence of some retail banners. Since the show is held on the west coast, not all east coast merchants had the opportunity to participate.

Next year, the show will return to Orlando, FL from October 15-17, 2026.

Related Topics:
Continue Reading

Cannabis News

Greenhouses and more at Fruit Logistica Berlin

Published

6 hours ago

on

February 9, 2026

By











New varieties, new concepts, new packaging, new products, new faces – there was a lot to do in Berlin last week. And, new travel schedules too: due to the black ice, many visitors traveling by plane had to extend their stay or find an alternative mode of transport – or both.

Click here for the photo report.

© Arlette Sijmonsma | MMJDaily.com

Fortunately, our bus drivers got us home safely to the Netherlands, and we were able to take all the photos of the greenhouse suppliers, growers and other related parties, so take a seat and enjoy our Fruit Logistica photo report!

There will be more updates this week, as well as extensive reports from our international Freshplaza colleagues, focused on the fresh produce industry.

Click here for the photo report.










Continue Reading

Cannabis News

Alaska Government Task Force Recommends Legalizing Psychedelic Therapy Upon FDA Approval

Published

6 hours ago

on

February 9, 2026

By

An Alaska psychedelic task force is recommending that the state move forward with plans to provide regulated access to psychedelics if the federal Food and Drug Administration (FDA) allows medical use of substances such as psilocybin and MDMA.

According to a law approved in 2024, after working for about a year studying the issue, Alaska Legislative Task Force on Psychedelic Drug Regulation released its findings and recommendations on Thursday.

“Alaska has one of the nation’s highest rates of domestic violence survivors and combat veterans suffering from PTSD, and many Alaskans continue to struggle with traditional treatments,” Sen. Forrest Dunbar (D), the task force’s leader, said in a press release.

“Our approach to these new medical therapies must be properly and independently evaluated so that if the legislature were to make policy changes, we will do so with empirical data in a properly controlled environment,” the senator said.

The panel’s report lists a number of findings based on a review of the scientific literature and expert testimony. This includes findings that some psychedelics do indeed have “potential therapeutic uses” and that “there is a particular focus on the use of these therapies for veterans, survivors of assault and interpersonal violence, and others with post-traumatic stress disorder (PTSD).

Members emphasized the importance of delivering psychedelic therapies in partnership with “multiple types of providers” to provide comprehensive treatment, rather than leaving it up to the patient.

Among its recommendations, the task force said, “If psychedelic medical therapies are approved by the FDA, the state should take steps to allow them to be used in Alaska, rather than ban their use.”

Alaska regulators should also identify clinical task forces, “whose role is to regularly review up-to-date studies and the evidence base to make recommendations, and rely on those entities to provide ongoing guidance on the use of these therapies,” he said.

“As much as possible, reserve the use of state statute for broad enabling language and essential components of a regulatory structure, and leave most regulatory decisions to the appropriate boards and agencies,” another recommendation reads. “Regulations still require a robust public process to be approved, but they are more predictable and can be updated or changed more easily than statutory amendments that require legislative action.”

“The appropriate parameters for the use of these therapies are likely to change over time as the evidence base matures and FDA approval may be granted for multiple therapies,” he said.

If the FDA continues to approve any psychedelics for medical use, the panel said the Alaska State Board of Medicine should update its guidelines for prescribing controlled substances to include new therapies.

Additionally, if the FDA approves psychedelic drugs and the Drug Enforcement Administration (DEA) federally reschedules substances such as psilocybin, Alaska “should fully reflect federal programming and Risk Evaluation and Mitigation Strategies (REMS), without adding duplicative or conflicting state regulations, and follow the rules for determining whether a DEA license is required.” the report he says

“This approach respects federal science and facilitates access for patients and providers,” he continues.

Additionally, as lawmakers and regulators await a federal decision to advance psychedelic therapies, states should consider legislation to “incorporate the recommendations made in this report to encourage statewide implementation action.”

“Legislation on triggers would require addressing various process and regulatory issues, such as the role and involvement of professional licensing boards, state agencies, and the Controlled Substances Advisory Committee,” the task force said.

The report also says that psychedelic reform should include military veterans’ access to FDA-approved therapies, which could involve working with the US Department of Veterans Affairs (VA) to identify opportunities to participate in clinical trials and pilot programs using new drugs.

“The grant should be considered to ensure active efforts by the American Medical Association (AMA) and the Centers for Medicare and Medicaid Services (CMS) to develop billing codes that will promote sufficient reimbursement for the provision of psychedelic therapy, which are essential to ensure patient access post-FDA approval,” the panel said.

Rep. Justin Ruffridge (R), who also serves as co-chair of the psychedelic panel, said the task force “focused on preparing Alaska for potential federal approval of psychedelic therapies.”

“These recommendations came from months of collaboration and work by medical professionals, advocates and legislators who focused on patient safety, evidence-based care and access, especially for those who have not seen progress through traditional treatments,” he said.

So far two other states have facilitated fully functioning psychedelic programs. Oregon voters legalized the therapeutic psilocybin in 2020and Colorado’s program was approved at the ballot box in 2022, with the state’s governor signing the legislation a year later to create the regulatory framework for the program

Meanwhile, a campaign in Alaska announced in December that it did not get enough signaturesAn initiative to legalize some psychedelics like psilocybin and DMT on the 2026 state ballot.– but the activists have emphasized that “the work is far from over” as they focus on putting the reform measure before the voters in 2028.

“While we won’t be on the ballot in 2026, we’re still on track for 2028, and with the determination, focus and support of our community, we’ll continue to move forward,” Natural Medicine Alaska said in December. “This movement is gaining momentum every day. In fact, 65 percent of Alaskans support this initiative, and that number continues to grow.”

A pre-campaign policy outline explained that the proposal is “under construction”. The Natural Medicine Health Act of 2022 passed by Colorado votersunder last year facilitators administered the state’s first legal dose of psilocybin.

A 2024 poll found that nearly half (49.4 percent) of Alaskan adults would support a ballot measure more broadly. remove criminal penalties for the use of substances such as psilocybin mushrooms.

That support rose significantly—to nearly two-thirds (65 percent)—when participants were told that Alaska has high rates of mental illness that could be treated with psychedelics.

Photo elements courtesy of the user carlosemmaskype and Apollo.

Marihuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Anti legalization group fails to collect signatures to roll back laws

Published

1 day ago

on

February 8, 2026

By











A Maine campaign seeking to significantly roll back the state’s marijuana law failed to submit signatures this week for the November 2026 ballot, meaning anti-cannabis activists will have to move to 2027 if they hope to get the issue before voters.

Amid criticism from reform advocates, industry players and some lawmakers for allegedly deceptive signature-gathering tactics, Mainers for a Safe and Healthy Future apparently couldn’t make the cut by the Feb. 2 deadline.

“Cannabis orders were not returned yesterday,” Assistant Secretary of State for Communications Jana Spaulding told Cannabis Business Times on Tuesday. In Maine, that doesn’t mean the campaign has to start from scratch, though, because they can still put the proposition on next year’s ballot. A Republican Maine lawmaker and marijuana industry advocates raised the alarm last month that prohibitionist campaigners were using deceptive petitions to get voters to sign the petition.

A video shared by Rep. David Boyer (R) appeared to feature an image and audio recording of a person gathering signatures for the ballot measure, in which he grossly misrepresented what the cannabis proposal would accomplish, saying its main goal was to ensure the product’s safety through improved testing.

Read more at Marijuana Moment










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media